Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of etravirine levels in cerebrospinal fluid in HIV-infected subjects
2010-022201-18Phase 4Active
- Sponsor
- Daniel Podzamczer
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etravirine in human immunodeficiency virus infection (HIV), sponsored by Daniel Podzamczer. Primary endpoints: Clinical parameters, Etravirine concentration in cerebrospinal fluid and 1 more. Started Jan 2011; status: active.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-022201-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022201-18.